MFIM
HRTX icon

Mesirow Financial Investment Management’s Heron Therapeutics HRTX Stock Holding History

Mesirow Financial Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,805
Closed -$232K – 73
2020
Q2 		$232K Buy
15,805
+670
+4% +$11K 1.09% 61
2020
Q1 		$178K Sell
15,135
-160
-1% -$3.01K 1.12% 56
2019
Q4 		$359K Sell
15,295
-7,370
-33% -$163K 1.52% 37
2019
Q3 		$419K Sell
22,665
-1,447
-6% -$26.6K 1.76% 24
2019
Q2 		$430K Buy
24,112
+4,559
+23% +$91.1K 1.57% 41
2019
Q1 		$478K Buy
19,553
+6,254
+47% +$164K 1.9% 19
2018
Q4 		$345K Buy
13,299
+2,603
+24% +$71.6K 2.23% 14
2018
Q3 		$339K Sell
10,696
-10,537
-50% -$392K 1.75% 29
2018
Q2 		$825K Sell
21,233
-12,156
-36% -$387K 3.67% 1
2018
Q1 		$922K Sell
33,389
-486
-1% -$11K 3.88% 1
2017
Q4 		$613K Buy
33,875
+601
+2% +$9.8K 2.78% 4
2017
Q3 		$537K Sell
33,274
-3,470
-9% -$54.4K 2.53% 8
2017
Q2 		$509K Buy
+36,744
New +$532K 2.4% 10

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Mesirow Financial Investment Management's HRTX Position: Q3 2020 in Review

Mesirow Financial Investment Management sold out of Heron Therapeutics (HRTX) in Q3 2020, closing a stake of 15,805 shares — an estimated $232K sold.

Mesirow Financial Investment Management first reported a position in HRTX in Q2 2017 and held it in 13 quarters. The position peaked at $922K in Q1 2018. 182 funds tracked by Wall St. Rank hold HRTX as of Q3 2020.

  • Mesirow Financial Investment Management reported no remaining Heron Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 15,805 Heron Therapeutics shares in Q3 2020, an estimated $232K.
  • Mesirow Financial Investment Management first reported a position in Heron Therapeutics in Q2 2017 and held it in 13 quarters.
  • Mesirow Financial Investment Management's Heron Therapeutics position peaked at $922K in Q1 2018.
  • 182 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2020.

Based on Mesirow Financial Investment Management's 13F filing for Q3 2020, filed 13 Oct 2020.